Our study aimed to evaluating significance of survivin as a prognostic marker of relapse in children with acute lymphoblastic leukemia. The study included 46 child (30 males, 16 females): 24 child with ALL at 35 day from BFM 95 Protocol and 22 relapse child with ALL.